

GOVX stock pulls back premarket after an 80% rally as GeoVax Labs announces a $3M private placement, sparking dilution fears.
You can purchase shares of Geovax Labs (NASDAQ:GOVX) through any online brokerage.
Other companies in Geovax Labs’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Geovax Labs has a consensus price target of $256.00.
The stock price for Geovax Labs (NASDAQ: GOVX) is $0.2101 last updated October 23, 2026 at 7:54 PM EDT.
There are no upcoming dividends for Geovax Labs.
Geovax Labs does not have any upcoming earnings scheduled.
There is no upcoming split for Geovax Labs.
Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a...